IgM nephropathy; time to act

IgM nephropathy; time to act

Bibliographic Details
Main Author:	Muhammed Mubarak
Format:	Article
Language:	English
Published:	Society of Diabetic Nephropathy Prevention 2014-01-01
Series:	Journal of Nephropathology
Subjects:	igm nephropathy minimal change disease iga nephropathy
Online Access:	https://nephropathol.com/PDF/jnp-3-22.pdf

Similar Items

Comment on: IgM nephropathy: Can we still ignore it
by: Muhammed Mubarak
Published: (2013-10-01)

IgM nephropathy; can we still ignore it
by: Aruna Vanikar
Published: (2013-04-01)

Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study
by: Gabriel Stefan, et al.
Published: (2024-12-01)

Oxford classification of IgA nephropathy: Broadening the scope of the classification
by: Muhammed Mubarak
Published: (2012-04-01)

Can erythema multiforme be an immune sequela of IgM nephropathy? A case report
by: Francesco Messina, et al.
Published: (2022-10-01)

Renal Outcome of IgM Nephropathy: A Comparative Prospective Cohort Study
by: Yura Chae, et al.
Published: (2021-09-01)

Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center
by: Mokhtar Ghadeer A., et al.
Published: (2014-04-01)

IgM nephropathy complicated by cerebral venous sinus thrombosis: a case study
by: Elizabeth Downie, et al.
Published: (2020-09-01)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
by: Haresh Selvaskandan, et al.
Published: (2020-10-01)

Characterization of patients with IgA nephropathy with and without associated minimal change disease
by: Wei-yi Guo, et al.
Published: (2023-02-01)

Cancer in IgA nephropathy; a letter to the editor on current findings
by: Maryam ALem, et al.
Published: (2024-01-01)

Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies
by: Muhammed Mubarak
Published: (2013-07-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
by: Francesca Zanoni, et al.
Published: (2023-08-01)

Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues
by: Rimlee Dutta, et al.
Published: (2023-01-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Extracapillary proliferation in IgA nephropathy; recent findings and new ideas
by: Hamid Nasri, et al.
Published: (2015-01-01)

Do IgA nephropathy presentations display any seasonality?
by: Adrian Y. S. Lee, et al.
Published: (2021-07-01)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
by: Huixian Li, et al.
Published: (2021-12-01)

MicroRNAs in IgA nephropathy
by: Xingchen Yao, et al.
Published: (2021-01-01)

Successful treatment of a rare variant of mesangioproliferative glomerulonephritis with IgM deposits with Cyclosporin A
by: Daria V. Gurova, et al.
Published: (2020-07-01)

IgA Nephropathy in a Patient Treated with Adalimumab
by: Tonja Mertelj, et al.
Published: (2021-07-01)

Late-onset rheumatoid arthritis in a patient with successfully treated IgA nephropathy
by: N V Chebotareva, et al.
Published: (2017-08-01)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
by: Soumita Bagchi, et al.
Published: (2021-06-01)

Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathy
by: Tsutomu Inoue, et al.
Published: (2019-01-01)

Clinicopathologic characteristics and outcomes of IgA nephropathy patients with different proportions of crescent
by: Chun-hua Liu, et al.
Published: (2024-01-01)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
by: Won-Hee Cho, et al.
Published: (2020-08-01)

Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy
by: M. Colleen Hastings, et al.
Published: (2018-01-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

The case of nutcracker phenomenon associated with IgA nephropathy
by: Medin Danilo V., et al.
Published: (2021-01-01)

Nomogram prediction model for renal anaemia in IgA nephropathy patients
by: Li Fei, et al.
Published: (2021-05-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
by: Da-Wei Lin, et al.
Published: (2022-03-01)

The coincidence of IgA nephropathy and Fabry disease
by: Maixnerová Dita, et al.
Published: (2013-01-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

Treatment of rapidly progressive IgA nephropathy with glucocorticoid plus telitacicept: one case report
by: Jia-xin Huang, et al.
Published: (2024-04-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
by: Dita Maixnerova, et al.
Published: (2021-09-01)

The clinical and pathological characteristics of IgA nephropathy patients in Tibet
by: Fenglei Si, et al.
Published: (2022-07-01)